1
|
An J, Yang J, Lee WH, Kim JB, Kim JK, Kim H, Paek SH, Lee JW, Woo J, Kwon H, Lim W, Paik NS, Kim YK, Moon BI. Abstract P2-02-09: Not presented. Cancer Res 2019. [DOI: 10.1158/1538-7445.sabcs18-p2-02-09] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
This abstract was not presented at the conference.
Citation Format: An J, Yang J, Lee W-H, Kim JB, Kim J-k, Kim H, Paek SH, Lee JW, Woo J, Kwon H, Lim W, Paik NS, Kim Y-K, Moon B-I. Not presented [abstract]. In: Proceedings of the 2018 San Antonio Breast Cancer Symposium; 2018 Dec 4-8; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2019;79(4 Suppl):Abstract nr P2-02-09.
Collapse
Affiliation(s)
- J An
- Ewha Womans University School of Medicine, Seoul, Republic of Korea; MD Healthcare Company, Seoul, Republic of Korea
| | - J Yang
- Ewha Womans University School of Medicine, Seoul, Republic of Korea; MD Healthcare Company, Seoul, Republic of Korea
| | - W-H Lee
- Ewha Womans University School of Medicine, Seoul, Republic of Korea; MD Healthcare Company, Seoul, Republic of Korea
| | - JB Kim
- Ewha Womans University School of Medicine, Seoul, Republic of Korea; MD Healthcare Company, Seoul, Republic of Korea
| | - J-k Kim
- Ewha Womans University School of Medicine, Seoul, Republic of Korea; MD Healthcare Company, Seoul, Republic of Korea
| | - H Kim
- Ewha Womans University School of Medicine, Seoul, Republic of Korea; MD Healthcare Company, Seoul, Republic of Korea
| | - SH Paek
- Ewha Womans University School of Medicine, Seoul, Republic of Korea; MD Healthcare Company, Seoul, Republic of Korea
| | - JW Lee
- Ewha Womans University School of Medicine, Seoul, Republic of Korea; MD Healthcare Company, Seoul, Republic of Korea
| | - J Woo
- Ewha Womans University School of Medicine, Seoul, Republic of Korea; MD Healthcare Company, Seoul, Republic of Korea
| | - H Kwon
- Ewha Womans University School of Medicine, Seoul, Republic of Korea; MD Healthcare Company, Seoul, Republic of Korea
| | - W Lim
- Ewha Womans University School of Medicine, Seoul, Republic of Korea; MD Healthcare Company, Seoul, Republic of Korea
| | - NS Paik
- Ewha Womans University School of Medicine, Seoul, Republic of Korea; MD Healthcare Company, Seoul, Republic of Korea
| | - Y-K Kim
- Ewha Womans University School of Medicine, Seoul, Republic of Korea; MD Healthcare Company, Seoul, Republic of Korea
| | - B-I Moon
- Ewha Womans University School of Medicine, Seoul, Republic of Korea; MD Healthcare Company, Seoul, Republic of Korea
| |
Collapse
|
2
|
Kim Y, Jung S, Yang E, Paik N. Clinical and sonographic risk factors for hemiplegic shoulder pain: A longitudinal observational study. J Rehabil Med 2014; 46:81-7. [DOI: 10.2340/16501977-1238] [Citation(s) in RCA: 27] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
|
3
|
Kim W, Jung S, Oh M, Min Y, Lim J, Paik N. Effect of repetitive transcranial magnetic stimulation over the cerebellum on patients with ataxia after posterior circulation stroke: A pilot study. J Rehabil Med 2014; 46:418-23. [DOI: 10.2340/16501977-1802] [Citation(s) in RCA: 54] [Impact Index Per Article: 5.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
|
4
|
Lee A, Chang J, Bang B, Lee J, Han D, Min S, Yun C, Kim BS, Lim W, Paik N, Moon BI. Abstract P4-03-11: SUVmax of FDG-PET/CT is Associated with Chemotherapy Response Assay Test Results and Prognostic Factors in Breast Cancer Patients. Cancer Res 2012. [DOI: 10.1158/0008-5472.sabcs12-p4-03-11] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Backgrounds:18F-fluorodeoxyglucose positron emission tomography with computed tomography (18F-FDG PET/CT) is widely used for cancer evaluation and there are several studies which suggested maximum standard uptake value (SUVmax) may reflect the cancer patients' prognosis. Adenosine triphosphate-based chemotherapy response assay (ATP-CRA) is commonly used as a chemosensitivity assay modality for the treatment of various cancers in clinical settings and there have been several studies on its usefulness in breast cancer. We previously reported chemosensitivity (ATP-CRA) results might reflect patients' prognosis. So we supposed that SUVmax could reflect chemosenitivity (ATP-CRA) results of patients, so performed this study to analyze the relationship between PET/CT SUVmax and chemosenstivity (ATP-CRA) results of these drugs. Furthermore, we evaluated prognostic factors for breast cancer according to SUVmax.
Materials and Methods: 102 breast cancer patients, who underwent PET/CT and chemosensitive (ATP-CRA) test between December 2010 and April 2012, were enrolled in this study. We analyzed, retrospectively, the correlation between SUVmax of PET/CT and chemosenitivity (ATP-CRA) results of doxorubicin/paclitaxel. SUVmax according to prognostic factors were also assessed.
Results: Chemosensitivity (ATP-CRA) results of doxorubicin and paclitaxel have significant positive correlation with SUVmax. Their correlation coefficient were 0.236 (p = 0.020) and 0.216 (p = 0.030), respectively. Patients with larger tumor size, higher histologic and nuclear grade, estrogen receptor negative, progesterone receptor negative, HER2 positive, and Ki67 positive (≥14%) have higher mean SUVmax values (p < 0.05). In molecular subgroup analysis, triple negative group showed higher mean SUVmax values than luminal A group (p < 0.001).
Conclusion: Higher SUVmax values of PET/CT is correlated with better chemosensitive (ATP-CRA) results of doxorubicin and paclitaxel, and poor prognostic factors of breast cancer. However, examination of additional cases might be needed.
Citation Information: Cancer Res 2012;72(24 Suppl):Abstract nr P4-03-11.
Collapse
Affiliation(s)
- A Lee
- Ewha Womans University Hospital, Seoul, Republic of Korea
| | - J Chang
- Ewha Womans University Hospital, Seoul, Republic of Korea
| | - B Bang
- Ewha Womans University Hospital, Seoul, Republic of Korea
| | - J Lee
- Ewha Womans University Hospital, Seoul, Republic of Korea
| | - D Han
- Ewha Womans University Hospital, Seoul, Republic of Korea
| | - S Min
- Ewha Womans University Hospital, Seoul, Republic of Korea
| | - C Yun
- Ewha Womans University Hospital, Seoul, Republic of Korea
| | - BS Kim
- Ewha Womans University Hospital, Seoul, Republic of Korea
| | - W Lim
- Ewha Womans University Hospital, Seoul, Republic of Korea
| | - N Paik
- Ewha Womans University Hospital, Seoul, Republic of Korea
| | - B-I Moon
- Ewha Womans University Hospital, Seoul, Republic of Korea
| |
Collapse
|
5
|
Kang E, Kim D, Paik N. Transcranial direct current stimulation of the left prefrontal cortex improves attention in patients with traumatic brain injury: A pilot study. J Rehabil Med 2012; 44:346-50. [DOI: 10.2340/16501977-0947] [Citation(s) in RCA: 64] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
|
6
|
Yi Y, Yang E, Kim J, Kim W, Min Y, Paik N. Predictive factors for removal of percutaneous endoscopic gastrostomy tube in post-stroke dysphagia. J Rehabil Med 2012; 44:922-5. [DOI: 10.2340/16501977-1050] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
|
7
|
|
8
|
Noh W, Paik N, Moon N, Kim M, Han S. P57 Ipsilateral breast tumor recurrence afterbreast-conserving therapy: A comparison of quadrantectomy versus lumpectomy in a single institution. Breast 2005. [DOI: 10.1016/s0960-9776(05)80096-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022] Open
|
9
|
Yu SH, Noh WC, Bang HY, Hwang DY, Choi DW, Lee JI, Paik NS, Moon NM, Jung JH. Sarcoma and Sarcomatous Metaplastic Carcinoma of the Breast. Cancer Res Treat 2001; 33:463-8. [PMID: 26680823 DOI: 10.4143/crt.2001.33.6.463] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022] Open
Abstract
PURPOSE Primary sarcoma and SMC (sarcomatous metaplastic carcinoma) of the breast are very rare tumors, accounting for less than 1% of all breast malignancies. There are many controversies concerning the biological characteristics, prognosis and optimal treatment of these tumors owing to the rarity of incidence. The aims of this study were to elucidate the clinicopathologic characteristics of these tumors and to assist in elucidating the optimal treatment plan for the disease. MATERIALS AND METHODS 13 cases of primary sarcoma and 10 cases of SMC that had been treated at KCCH between 1984 and 2001 were retrospectively reviewed. Phyllodes tumors were excluded from our study. RESULTS Among the 13 cases of primary sarcoma included, stromal sarcoma occurred in 5 cases, osteosarcoma in 3 cases, angiosarcoma in 3 cases and spindle cell sarcoma in 2 cases. The mean age of the patients with primary sarcoma and SMC was 39.7 years and 55.1 years respectively (p=0.002). When survival rates were compared according to histologic types, size of tumor, histologic grade, type of surgery and use of adjuvant therapy, both size of tumor (p=0.0256) and histologic grade (p=0.0197) were shown to be prognostic factors. CONCLUSION There were no significantly different features between primary sarcoma and SMC in terms of biologic characteristics or survival rates, with the exception that patients with SMC were older than those with primary sarcoma. Histologic grade and size of tumor were significant prognostic factors of these tumors.
Collapse
|
10
|
Park SC, Lim IK, Paik NS, Yamamoto T, Yuasa Y, Nakachi K, Fujiki H. Japan-Korea Cancer Research Symposium: investigation on the balanced cooperation of cancer cells with the human body. J Cancer Res Clin Oncol 2001; 127:692-5. [PMID: 11710600 DOI: 10.1007/s004320100279] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
Affiliation(s)
- S C Park
- Department of Biochemistry and Molecular Biology, Seoul National University College of Medicine, Korea
| | | | | | | | | | | | | |
Collapse
|
11
|
Kang WK, Park C, Yoon HL, Kim WS, Yoon SS, Lee MH, Park K, Kim K, Jeong HS, Kim JA, Nam SJ, Yang JH, Son YI, Baek CH, Han J, Ree HJ, Lee ES, Kim SH, Kim DW, Ahn YC, Huh SJ, Choe YH, Lee JH, Park MH, Kong GS, Park EY, Kang YK, Bang YJ, Paik NS, Lee SN, Kim SH, Kim S, Robbins PD, Tahara H, Lotze MT, Park CH. Interleukin 12 gene therapy of cancer by peritumoral injection of transduced autologous fibroblasts: outcome of a phase I study. Hum Gene Ther 2001; 12:671-84. [PMID: 11426466 DOI: 10.1089/104303401300057388] [Citation(s) in RCA: 99] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022] Open
Abstract
A phase I dose-escalation clinical trial of peritumoral injections of interleukin 12 (IL-12)-transduced autologous fibroblasts was performed in patients with disseminated cancer for whom effective treatment does not exist. The goals of this study were to assess the safety and toxicities as well as the efficacy, and ancillarily the immunomodulatory effects, of peritumoral IL-12 gene transfer. Primary dermal fibroblasts cultured from the patients were transduced with retroviral vector carrying human IL-12 genes (p35 and p40) as well as the neomycin phosphotransferase gene (TFG-hIL-12-Neo). Patients received four injections at intervals of 7 days. Nine patients were enrolled in this dose-escalation study, with secreted IL-12 doses ranging from 300 ng/24 hr for the first three patients to 1000, 3000, and 5000 ng/24 hr for two patients in each subsequent dosage level. Although a definite statement cannot be made, there appears to be perturbation of systemic immunity. Also, the locoregional effects mediated by tumor necrosis factor alpha (TNF-alpha) and CD8+ T cells were observed with tumor regression. Treatment-related adverse events were limited to mild to moderate pain at the injection site; clinically significant toxicities were not encountered. Transient but clear reductions of tumor sizes were observed at the injected sites in four of nine cases, and at noninjected distant sites in one melanoma patient. Hemorrhagic necrosis of tumors was observed in two melanoma patients. These data indicate that gene therapy by peritumoral injection of IL-12-producing autologous fibroblasts is feasible, and promising in patients with advanced cancer.
Collapse
Affiliation(s)
- W K Kang
- Cancer Center, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
12
|
Abstract
Data are presented on the externally received personal dose equivalent for radiation workers who used the Korea Radioisotope Association's personal monitoring and dose record keeping service since 1984, and provide initial statistics on Korean workers who have been exposed to ionising radiation in different occupations. The total number of workers registered during the period of 1984 to 1999 was 64,518. The number increased steadily and the accumulated dose also increased. The proportion of radiation workers by occupation was 38.4% for nuclear power plants, 20.3% for industrial organisations and 12.4% for non-destructive industry. The annual collective dose of radiation workers was 31.72 man.Sv in 1999. The mean annual dose by sex was 1.49 mSv for males and 0.56 mSv for females and the mean annual dose for a worker was 1.41 mSv with the highest mean dose being received by non-destructive industry (3.53 mSv). Very few workers (0.8%) received more than 20 mSv (2 rem) and only one more than 50 mSv, the legal limit for an annual dose increase. There has been a steady decline in the mean dose since 1984, showing a significant decrease in dose with time (p<0.001). The data showed that radiation protection in Korea was improving, though annual doses were still higher than other countries.
Collapse
Affiliation(s)
- S Y Choi
- Laboratory of Clinical Research, Korea Cancer Center Hospital, Seoul.
| | | | | | | | | |
Collapse
|
13
|
Abstract
The specific binding of [3H]retinoids to cellular retinoid-binding proteins was measured directly by the cold acetone filtration method. After incubation of purified cellular retinoid-binding proteins with [3H]retinoids with or without competitors for 2-4 h, bound ligands were separated from free by filtration using cold acetone. Nonspecific binding of the ligands was reduced sufficiently to allow measurement of specific binding of [3H]retinoids to cellular retinoid-binding proteins. This method has the advantages of being rapid and practical and giving reproducible results.
Collapse
Affiliation(s)
- M Ninomiya
- National Cancer Center Research Institute, Tokyo, Japan
| | | | | | | | | |
Collapse
|
14
|
Ninomiya M, Fujiki H, Paik NS, Horiuchi T, Boutwell RK. Absence of phosphorylation of retinoid-binding proteins by protein kinase C in vitro. Biochem Biophys Res Commun 1986; 138:330-4. [PMID: 3017322 DOI: 10.1016/0006-291x(86)90284-6] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/03/2023]
Abstract
Cellular retinol-binding protein, cellular retinoic acid-binding protein, and fetal cellular retinol-binding protein were purified to homogeneity and each polypeptide had a molecular weight of 16,000. Their apoproteins were not phosphorylated under the same conditions. Their holoproteins did not inhibit the phosphorylation of histone III-S by protein kinase C. Each of these observations is contrary to the results reported by Cope et al. (Biochem. Biophys. Res. Commun., 120, 593-601, 1984).
Collapse
|
15
|
Ninomiya M, Fujiki H, Paik NS, Hakii H, Suganuma M, Hitotsuyanagi Y, Aimi N, Sakai S, Endo Y, Shudo K. Des-O-methylolivoretin C is a new member of the teleocidin class of tumor promoters. Jpn J Cancer Res 1986; 77:222-5. [PMID: 3084411] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/04/2023] Open
Abstract
Des-O-methylolivoretin C, a demethylated form of olivoretin C, is a naturally occurring compound in Streptomyces mediocidicus and Streptoverticillium olivoreticuli. Des-O-methylolivoretin C is a regioisomer of teleocidin B, which has the same activity as teleocidin. The tumor-promoting activity of des-O-methylolivoretin C was studied in a two-stage carcinogenesis experiment on mouse skin in comparison with that of teleocidin. Treatments with 7,12-dimethylbenz[a]anthracene (DMBA) plus des-O-methylolivoretin C and DMBA plus teleocidin induced tumors in 63.3% and 84.6% of the mice, respectively, in week 30. The difference in the tumor-promoting activities of des-O-methylolivoretin C and teleocidin is presumably related to the regioisomeric difference in the cyclohexene ring.
Collapse
|
16
|
Paik N. [Application of moiré topography for the evaluation of anterior chest deformities]. Nihon Kyobu Geka Gakkai Zasshi 1984; 32:885-93. [PMID: 6491402] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/20/2023]
|
17
|
Kawamura T, Paik N, Wada J. [Computerized Moiré topography before and after surgery of funnel chest]. Kyobu Geka 1983; 36:968-70. [PMID: 6672398] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/21/2023]
|
18
|
|
19
|
Paik NS, Wada J, Kawamura T, Saso M, Hino T, Nagara H, Yokoyama M. [Successful treatment of dissecting aortic aneurysm discovered during weaning from extracorporeal circulation]. Nihon Kyobu Geka Gakkai Zasshi 1983; 31:396-400. [PMID: 6631131] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/21/2023]
|
20
|
Kawamura T, Paik NS, Yamaguchi A. [New moire topography apparatus for decubitus position for the evaluation of thoracic deformities]. Kokyu To Junkan 1982; 30:1109-11. [PMID: 7167679] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/23/2023]
|
21
|
Paik NS. [Two surgical cases of Poland's syndrome (author's transl)]. Nihon Kyobu Shikkan Gakkai Zasshi 1980; 18:913-7. [PMID: 6259397] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/19/2023]
|
22
|
Matsushita I, Paik NS, Itaoka T, Kawamura T, Wada J. [Antibiotic concentration during extracorporeal circulation (author's transl)]. Jpn J Antibiot 1980; 33:705-10. [PMID: 7452909] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/25/2023]
Abstract
In open surgery, ampicillin (Solcillin) or cephacetrile (Celtol), 2 g for patients weighing 20 kg or more, and 1 g for those below 20 kg, was administered, and the antibiotic concentrations in blood and urine were estimated during extracorporeal circulation, from the time of operation to the admission in an intensive care unit (Group A). In other group, a total circulation volume of 0.3 mg/ml of the antibiotic was administered, based on body weight of patients and priming volumes (Group B). In Group A, blood concentration of antibiotics was so variable that it was difficult to decide additional dosage. In Group B, comparatively definite concentrations were estimated in each case. In extracorporeal circulation for a long time, it is preferable to maintain the blood concentration of antibiotic at 50 micrograms/ml, by additional antibiotic administration 90 approximately 120 minutes after the beginning of the extracorporeal circulation. In patients with preoperative subacute bacterial endocarditis, the blood concentration should be kept over 100 micrograms/ml during extracorporeal circulation.
Collapse
|